PAPER Franceschi AM, Naser-Tavakolian K, Clifton M, Ahmed O, Stoffers K, Bangiyev L, Cruciata G, Clouston S, Franceschi D

Hybrid imaging in dementia: A semi-quantitative (18F)-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging approach in clinical practice.

World J Nucl Med. 2021 Jan-Mar;20(1):23-31. Epub 2020 Oct 2 PubMed.

PAPER Sarikaya I, Kamel WA, Ateyah KK, Essa NB, AlTailji S, Sarikaya A

Visual versus semiquantitative analysis of 18F- fluorodeoxyglucose-positron emission tomography brain images in patients with dementia.

World J Nucl Med. 2021 Jan-Mar;20(1):82-89. Epub 2021 Jan 20 PubMed.

PAPER Chotipanich C, Jantarato A, Kunawudhi A, Kongthai S, Promteangtrong C

11C-Pittsburgh compound B and 18F-THK 5351 positron emission tomography brain imaging in cognitively normal individuals.

World J Nucl Med. 2021 Apr-Jun;20(2):133-138. Epub 2020 Jun 27 PubMed.

PAPER Franceschi AM, Clifton M, Naser-Tavakolian K, Ahmed O, Cruciata G, Bangiyev L, Clouston S, Franceschi D

(18F)-Fluorodeoxyglucose positron emission tomography/magnetic resonance imaging assessment of hypometabolism patterns in clinical phenotypes of suspected corticobasal degeneration.

World J Nucl Med. 2021 Apr-Jun;20(2):176-184. Epub 2020 Oct 7 PubMed.

PAPER Franceschi AM, Naser-Tavakolian K, Clifton M, Bangiyev L, Cruciata G, Clouston S, Franceschi D

Metabolic positron-emission tomography/magnetic resonance imaging in primary progressive aphasia and frontotemporal lobar degeneration subtypes: Reassessment of expected [18F]-fluorodeoxyglucose uptake patterns.

World J Nucl Med. 2021 Jul-Sep;20(3):294-304. Epub 2021 May 26 PubMed.

PAPER Morley NC, Hofer M, Wilkinson P, Bradley KM

18FDG PET-CT in sporadic Creutzfeldt-Jakob disease, correlated with MRI and histology.

World J Nucl Med. 2021 Oct-Dec;20(4):411-413. Epub 2021 Oct 12 PubMed.

PAPER Kritikos M, Franceschi AM, Vaska P, Clouston SA, Huang C, Salerno M, Deri Y, Tang C, Pellecchia A, Santiago-Michels S, Sano M, Bromet EJ, Lucchini RG, Gandy S, Luft BJ

Assessment of Alzheimer's Disease Imaging Biomarkers in World Trade Center Responders with Cognitive Impairment at Midlife.

World J Nucl Med. 2022 Dec;21(4):267-275. Epub 2022 Sep 2 PubMed.

PAPER Franceschi AM, Petrover DR, Giliberto L, Clouston SA, Gordon ML

Semiquantitative Approach to Amyloid Positron Emission Tomography Interpretation in Clinical Practice.

World J Nucl Med. 2023 Mar;22(1):15-21. Epub 2022 Oct 28 PubMed.

PAPER Mashriqi F, Mishra BB, Giliberto L, Franceschi AM

18 F-FDG Brain PET/MRI in Amyotrophic Lateral Sclerosis- Frontotemporal Spectrum Disorder (ALS-FTSD).

World J Nucl Med. 2023 Jun;22(2):135-139. Epub 2023 May 1 PubMed.

PAPER Downey CL, Young A, Burton EF, Graham SM, Macfarlane RJ, Tsapakis EM, Tsiridis E

Dementia and osteoporosis in a geriatric population: Is there a common link?

World J Orthop. 2017 May 18;8(5):412-423. PubMed.

PAPER Pandey S, Bapat V, Abraham JN, Abraham NM

Long COVID: From olfactory dysfunctions to viral Parkinsonism.

World J Otorhinolaryngol Head Neck Surg. 2024 Jun;10(2):137-147. Epub 2024 Apr 8 PubMed.

PAPER Humpel C, Hochstrasser T

Cerebrospinal fluid and blood biomarkers in Alzheimer's disease.

World J Psychiatry. 2011 Dec 31;1(1):8-18. PubMed.

PAPER Gerdner LA

Individualized music for dementia: Evolution and application of evidence-based protocol.

World J Psychiatry. 2012 Apr 22;2(2):26-32. PubMed.

PAPER Ehrlich D, Humpel C

Platelets in psychiatric disorders.

World J Psychiatry. 2012 Dec 22;2(6):91-4. PubMed.

PAPER Evin G, Li QX

Platelets and Alzheimer's disease: Potential of APP as a biomarker.

World J Psychiatry. 2012 Dec 22;2(6):102-13. PubMed.